MIRA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8 USD | -8.98% |
|
-9.09% | -23.81% |
| 29/05 | Sector Update: Health Care Stocks Fall Late Afternoon | MT |
| 29/05 | Sector Update: Health Care Stocks Retreat Wednesday Afternoon | MT |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 15.52 | 11.82 | - |
| Enterprise Value (EV) 1 | 15.52 | 11.82 | 11.82 |
| P/E ratio | -1.64 x | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 14,781 | 14,781 | - |
| Reference price 2 | 1.050 | 0.8000 | 0.8000 |
| Announcement Date | 01/04/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA | - | - | - | - |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) | -7.058 | - | - | - |
| Net income 1 | -7.058 | -11.98 | -8.476 | -8.559 |
| Net margin | - | - | - | - |
| EPS | - | -0.6400 | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 29/06/23 | 01/04/24 | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income 1 | - | - | - | -1.849 | -2.938 | -3.086 | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 15/09/23 | 13/11/23 | 13/05/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 29/06/23 | 01/04/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.81% | 1.3Cr | |
| +52.36% | 5.67TCr | |
| -3.86% | 4.1TCr | |
| +38.14% | 3.81TCr | |
| -12.01% | 2.69TCr | |
| +14.13% | 2.56TCr | |
| -21.62% | 1.86TCr | |
| +0.21% | 1.24TCr | |
| +25.96% | 1.2TCr | |
| +23.02% | 1.19TCr |
- Stock Market
- Equities
- MIRA Stock
- Financials MIRA Pharmaceuticals, Inc.
